Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-011010

Chief Medical Officer sold 3,156 shares at an average $70.33 ($221,972)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2021-02-11 Sale −2,756 $70.17 $193,377 172,633 I
Ho Carole Chief Medical Officer 2021-02-11 Sale −400 $71.49 $28,594 172,233 I
Open-market sales · 3,156 sh · avg $70.33 · $221,972
Loading xslF345X03/doc4.xml…